CDNA Breakout: CareDx Hits A New 52-Week High After Raising Its Outlook

CareDx (CDNA) jumped 14.7% in the latest session and closed at a fresh 52-week high of 43.71 after raising its full-year guidance following a strong second-quarter report, according to Yahoo Finance market movers. The stock traded as high as 45.00 on roughly three times its average volume, extending a rally that has pushed it about 50% higher in four weeks. The technical conflict is a clear one: an overbought breakout into uncharted price territory versus the risk of a fast mean-reversion pullback.

Why This Setup Matters Now

CDNA entered the technical-analysis queue as a leading name on the Yahoo Finance day gainers screen, where it posted one of the largest percentage gains in the session. The move followed a second-quarter report showing revenue of 131.9 million, up 52% year over year, non-GAAP EPS of 0.37 versus the 0.23 consensus, and an increase in full-year revenue guidance to 490 to 500 million, as covered by The Motley Fool and Zacks. The stock had already surged in mid-July after CMS affirmed coverage for CareDx surveillance testing across kidney, heart, and lung transplant programs, setting the stage for the breakout.

Metric	Value
Symbol	CDNA (NasdaqGS)
Name	CareDx, Inc.
Close	43.71
Daily change	+14.7%
Day range	40.67 - 45.00
Volume vs 3-month average	2.78M vs 0.94M (3.0x)
52-week range	11.26 - 45.00
Market cap	~2.3B
Source	Yahoo Finance

Quick Read

The main technical question is whether this breakout can hold after a four-week advance of nearly 50% from a tight base.

Question	Read
What happened?	52-week-high breakout on earnings and guidance hike
Catalyst	Q2 beat, revenue up 52%, FY26 guide raised
Trend status	Above all four major moving averages
Bias	Bullish but overbought

Technical Bias

The scorecard is strongly bullish on trend structure, but momentum is stretched after the vertical advance.

Factor	Reading
Price vs 20-day SMA (34.4)	+27%, extended
Price vs 50-day SMA (28.3)	+54%, strong uptrend
Price vs 200-day SMA (20.9)	+108%, long-term uptrend
RSI (14)	77.4, overbought
5-day change	+17.7%, accelerating
Volume on breakout	~3.0x average, conviction
Net bias	Bullish, extended short term

Key Levels To Watch

The stock has no overhead supply above 45.00 because it is making new highs, so levels below the close carry the most weight.

Level	Type
45.00	52-week high / round number
43.71	Current close
40.67	Session low / first pullback zone
38.00 - 38.50	Prior breakout shelf, derived zone
34.40	20-day SMA, derived zone
28.30	50-day SMA, not confirmed historical support

Scenario Map

Scenario	Trigger	Likely Path
Breakout extends	Close above 45.00	Price discovery, derived targets 48 to 50
Healthy pullback	Hold the 38 to 41 zone	Consolidate, then retry 45
Breakout fails	Close below 38.00	Retest 35 to 36, then 20-day SMA near 34

Momentum And Volume Check

Momentum is strong but hot. RSI near 77 and a three-fold volume expansion confirm real demand, yet they also flag an overbought condition that often precedes a pause.

Indicator	Value	Signal
RSI (14)	77.4	Overbought
20-day change	+49.7%	Extended
5-day change	+17.7%	Accelerating
Volume ratio	3.0x average	Strong demand
Close location	Near day high	Buyers in control

What Would Change The View

Signal	Meaning
Close above 45.00	Breakout confirmed, bullish continuation
Pullback holds above 40.67	Healthy, trend intact
Close below 38.00	Momentum damage, view turns neutral
Volume dries up on rally	Weak follow-through

Bottom line: CDNA remains bullish as long as it holds above 40. A move above 45.00 would strengthen the breakout, while a break below 38.00 would weaken the chart.

Summary

• CDNA rose 14.7% to 43.71 and tagged a 52-week high of 45.00 on roughly three times average volume, leading the Yahoo Finance day gainers screen.
• The move followed a Q2 beat with revenue up 52% year over year and an increase in full-year guidance.
• Price trades above the 20-day, 50-day, 100-day, and 200-day moving averages, but RSI near 77 signals an overbought condition.
• Key levels are 45.00 resistance and 40.67 support, with the 20-day SMA near 34 as a deeper reference.
• Bias is bullish while the stock holds above 40; a close below 38 would signal momentum damage.

Disclaimer

This article is for informational purposes only and does not constitute financial advice. Technical indicators can help frame risk and momentum, but they do not guarantee future price movement.